Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

March 24, 2017

Study Completion Date

March 24, 2017

Conditions
Type 1 Diabetes
Interventions
DRUG

Metformin

Six week intervention: Study drug/placebo will be given in a forced uptitration with 500 mg once daily for one week, 500 mg twice daily for one week, 500/1000 for one week, and then 1000mg twice daily for the remainder of the 6 week intervention. If uptitration is not tolerated, max dose will be max tolerated dose of at least 500 mg twice daily.

DRUG

Placebo

Six-week intervention: Study drug/placebo will be given in a forced uptitration with 500 mg once daily for one week, 500 mg twice daily for one week, and then the higher dose (850 mg) for the remainder of the 6 week intervention.

Trial Locations (1)

80045

University of Colorado Denver, Aurora

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

University of Colorado, Denver

OTHER

NCT01813929 - Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes | Biotech Hunter | Biotech Hunter